Management of Coronary Artery Disease with Moderate to Severe Mid LAD Stenosis and Elevated Calcium Score

Classification and Risk Assessment

The American College of Cardiology recommends classifying patients with 70-99% stenosis in mid LAD as CAD-RADS 4, indicating significant coronary artery disease requiring intervention, with a calcium score of 243.8 indicating moderate coronary calcification and increased risk for cardiovascular events 1, 2, 3

The American College of Radiology recommends referring patients with significant mid LAD stenosis for invasive coronary angiography (ICA) to confirm the severity of the stenosis and evaluate for potential revascularization, with consideration of functional assessment of the stenosis during ICA (FFR/iFR) to determine hemodynamic significance 1, 4, 5, 6
The European Heart Society recommends revascularization for significant mid LAD stenosis (70-99%) to improve symptoms and reduce adverse outcomes, with options including percutaneous coronary intervention (PCI) with stenting of the LAD, or coronary artery bypass grafting (CABG) if the anatomy is complex or less amenable to PCI 6

The American College of Cardiology recommends initiating aggressive risk factor modification and preventive pharmacotherapy, including high-intensity statin therapy to lower LDL-C, antiplatelet therapy (aspirin), and consideration of beta-blockers for symptom control, as well as ACE inhibitors/ARBs, especially if hypertension or diabetes is present 1, 2, 5, 6

The American College of Radiology recommends evaluating a 19mm right hilar lymph node separately, with correlation with complete blood count, consideration of additional chest imaging (CT chest without contrast) for better characterization, and depending on clinical context, consideration of pulmonary consultation or biopsy if lymphadenopathy persists 4
Regular cardiac follow-up, repeat functional testing (stress test) 6-12 months after intervention, and annual assessment of cardiovascular risk factors and medication adherence are recommended 5
The American College of Cardiology emphasizes that even with revascularization, aggressive medical therapy and risk factor modification remain essential components of management 1, 5